Shares of spinal implant manufacturer Globus Medical, Inc. (GMED) are rising in their trading debut on the New York Stock Exchange Friday, following a successful initial public offering.
The Audubon, Pennsylvania-based company priced its initial public offering of about 8.3 million shares of Class A common stock, consisting of about 2.1 million shares offered by Globus Medical and 6.25 million shares offered by selling shareholders, at $12 per share, the low end of an expected $12 to $13 range.
In addition, Globus Medical has granted the underwriters a 30-day option to purchase up to an additional 1.25 million shares of common stock to cover any over-allotments.
The offering is expected to close on August 8.
Earlier this week, Globus Medical reduced its planned IPO size to 8.3 million shares and estimated price range to $12 to $13 per share from its earlier plan to sell 11.8 million shares in a price range of $16 to $18 per share.
Globus Medical shares are currently trading at $13.99 after trading as high as $14.65 earlier in the session.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.